Gynecomastia in patients with prostate cancer: update on treatment options.
about
Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic reviewDrug-induced gynecomastia.Treatment of bicalutamide-induced breast events.Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
P2860
Gynecomastia in patients with prostate cancer: update on treatment options.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Gynecomastia in patients with prostate cancer: update on treatment options.
@ast
Gynecomastia in patients with prostate cancer: update on treatment options.
@en
type
label
Gynecomastia in patients with prostate cancer: update on treatment options.
@ast
Gynecomastia in patients with prostate cancer: update on treatment options.
@en
prefLabel
Gynecomastia in patients with prostate cancer: update on treatment options.
@ast
Gynecomastia in patients with prostate cancer: update on treatment options.
@en
P2093
P2860
P356
P1476
Gynecomastia in patients with prostate cancer: update on treatment options.
@en
P2093
Autorino R
Cosentino L
D'Armiento M
Di Lorenzo G
P2860
P2888
P304
P356
10.1038/SJ.PCAN.4500859
P577
2006-01-24T00:00:00Z